INFORME DIARIO 04 MARZO + RDOS. EUROPA 4T’24. PREVIEWS (ANÁLISIS BANCO...

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CELLNEX, ENAGÁS, MELIÁ. EUROPA: SECTOR AUTO, SIEMENS. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’24 que se publicarán en España y Europa en los próximos días. El Ibex a un paso de los 13.400 puntos Las bolsas de Europa volvieron a acercarse a los máximos del año, a pesar de los numerosos frentes que ...

IBERIAN DAILY 04 MARCH (ANÁLISIS BANCO SABADELL)

NEWS SUMMARY: CELLNEX, ENAGÁS, MELIÁ. The Ibex near 13,400 points European stock markets traded near the highs hit in the last few days amid many concerns (tariffs to Canada and Mexico will come into force next Tuesday and the situation in Ukraine is uncertain given the commitment of the Trump administration). Thus, in the STOXX 600, Industrials (fuelled by defence companies) and Basic Resources were the best performers vs. Real Estate and Utilities that were the only sectors ending in negativ...

Enagas SA: 1 director

A director at Enagas SA bought 12,396 shares at 12.110EUR and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

ODDO BHF Small & MIDCAP MORNING NEWS – 02/19/2025

ODDO BHF Small & MIDCAP MORNING NEWS – 19/02/2025

Enagas : Strategic update reflects cash flow resilience

ENAGÁS: FY2024 RESULTS AND STRATEGIC PLAN UPDATE (ANÁLISIS BANCO SABAD...

4Q'24 vs. 4Q'23 Results EBITDA: € 187.0 M (-10.1% vs. -19.7% BS(e) and -18.8% consensus); Net Profit: € 76.5 M (-7.8% vs. -21.7% BS(e) and -27.7% consensus); FY2024 vs. FY2023 Results EBITDA: € 760.7 M (-2.5% vs. -5.1% BS(e) and -4.9% consensus); Net Profit: € 310.1 M (+3.2% vs. -1% BS(e) and -7% consensus);

ENAGÁS: RDOS. 2024 Y ACTUALIZACIÓN PLAN ESTRATÉGICO (ANÁLISIS BANCO SA...

Rdos. 4T'24 vs 4T'23: EBITDA: 187,0 M euros (-10,1% vs -19,7% BS(e) y -18,8% consenso); BDI: 76,5 M euros (-7,8% vs -21,7% BS(e) y -27,7% consenso); Rdos. 2024 vs 2023: EBITDA: 760,7 M euros (-2,5% vs -5,1% BS(e) y -4,9% consenso); BDI: 310,1 M euros (+3,2% vs -1% BS(e) y -7% consenso);

Coffee, Croissants & Credit/Enagas

Utilities: Enagas 2024 results: Lower debt helps the case

IBERIAN DAILY 18 FEBRUARY + 4Q’24 RESULTS. PREVIEWS (ANÁLISIS BANCO SA...

NEWS SUMMARY: ENAGÁS. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 4Q’24 results to be released over the coming days in Spain. Stock markets at record highs European stock markets rallied, hitting new highs, driven by defence companies, in a session marked by the geopolitical news and amid talks to find an end to the war in Ukraine. In the STOXX 600, Industrials (underpinned...

INFORME DIARIO 18 FEBRERO + RDOS. ESPAÑA Y EUROPA 4T’24. IDEAS DESTACA...

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ENAGÁS. EUROPA: AIRBUS, ENI, UNICREDIT. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’24 que se publicarán en España y Europa en los próximos días. Bolsas en máximos históricos Subidas en las bolsas de Europa y Alemania, que marcaron nuevos máximos impulsadas por las empresas de defensa en una sesión d...

Distribuidora Internacional De Alimentacion: 1 director

A director at Distribuidora Internacional De Alimentacion bought 3,846,153 shares at 0.020EUR and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors...

ODDO BHF Small & MIDCAP MORNING NEWS – 12/23/2024

ODDO BHF Small & MIDCAP MORNING NEWS – 23/12/2024

Enagas : GSP arbitration: a shade below expectations but clears the wa...

IBERIAN DAILY 23 DECEMBER (ANÁLISIS BANCO SABADELL)

NEWS SUMMARY: ENAGÁS, CAF, LAR ESPAÑA. A week of corrections in view of the delay in rate cut expectations in the US US stock exchanges rallied last Friday with the good inflation data (core deflator) but slid near -1.5% last week vs. -2.0% European stock markets due to the fewer rate cuts expected by the Fed in 2025. Thus, in the STOXX 600 all sectors ended with drops last week, led by Pharma and Basic Resources vs. the better relative performance of Consumer Goods and Technology. On the macro...

INFORME DIARIO 23 DICIEMBRE (ANÁLISIS BANCO SABADELL)

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CAF, ENAG, LAR ESPAÑA. Semana de caídas en bolsa ante el retraso en las expectativas de bajadas de tipos en EE.UU. Las bolsas de EE.UU. rebotaron el viernes con el buen dato de inflación (deflactor del consumo) pero se dejaron en la semana cerca de un -1,5% y las europeas un -2,0%, acusando las menores bajadas de tipos previstas para 2025 por parte de la Fed. Así, en el STOXX 600, todos los sectores cerraron la semana con caídas, lideradas por Far...

Enagas/Debt reduction leads to neutral view

Enagas reported 9M24 results last week. Following this, we have changed our opinion on Enagas from negative to neutral. The Spanish utility sold its stake in Tallgrass in July 2024, reducing its indebtedness. Fitch Ratings and Standard & Poor's have upgraded Enagas to BBB+ and Moody's now has the issuer on a positive outlook (rating at Baa2). What restrains us from being positive on Enagas is the coming regulatory review and possibly further lower remuneration on Spanish gas pipelines. We also s...

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 10/23/2024

Last week, we organised an Expert Access event on multiple sclerosis (MS) with the participation of Dr Géraldine Androdias, a neurologist at Lyon University Hospital. Dr Androdias presented the key points of the ECTRIMS 2024 conference, as well as new trends in treating the illness. We note an unmet need in the primary progressive and secondary progressive forms, a real interest for the BTKi class with the greater penetration of the blood-brain barrier, and expectations for the anti-C...

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 23/10/2024

Nous avons organisé la semaine dernière un Expert Access autour de la sclérose en plaques (SEP) avec la participation du Dr Géraldine Androdias, médecin neurologue au CHU de Lyon. Le Dr Androdias a présenté les points saillants du congrès de l’ECTRIMS 2024 ainsi que les nouvelles tendances dans la prise en charge de la maladie. Nous retenons un besoin insatisfait dans les formes progressives et secondairement progressives, un vrai intérêt de la classe des BTKi avec le passage accru de...